{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:37:00Z","timestamp":1792499820372,"version":"4.5.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115495","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:22:15Z","timestamp":1758068535000},"page":"115495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Sepsis-induced ALI\/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies"],"prefix":"10.1016","volume":"166","author":[{"given":"Muhammad Qasim","family":"Barkat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Salawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaddique","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0005","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0010","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-012-2682-1","article-title":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material","volume":"38","author":"Ferguson","year":"2012","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome, the New England journal of medicine N","volume":"377","author":"Thompson","year":"2017","journal-title":"Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"16","key":"10.1016\/j.intimp.2025.115495_bb0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.intimp.2025.115495_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of Sepsis and potential therapeutic targets","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1164\/rccm.201512-2544CP","article-title":"Toward smarter lumping and smarter splitting: rethinking strategies for Sepsis and acute respiratory distress syndrome clinical trial design","volume":"194","author":"Prescott","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115495_bb0040","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00134-015-3822-1","article-title":"A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators","volume":"41","author":"Angus","year":"2015","journal-title":"Intensive Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ccc.2021.05.005","article-title":"Pathophysiology of the acute respiratory distress syndrome: insights from clinical studies","volume":"37","author":"Sinha","year":"2021","journal-title":"Crit. Care Clin."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10040897","article-title":"The role of macrophages in the development of acute and chronic inflammatory lung diseases","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115495_bb0055","article-title":"Classic signaling pathways in alveolar injury and repair involved in Sepsis-induced ALI\/ARDS: new research Progress and Prospect","volume":"2022","author":"Li","year":"2022","journal-title":"Dis. Markers"},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0060","first-page":"L1102","article-title":"Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS","volume":"308","author":"Kangelaris","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002022","article-title":"The clinical challenge of Sepsis identification and monitoring","volume":"13","author":"Vincent","year":"2016","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0070","first-page":"252","article-title":"Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment","volume":"107","author":"Matuschak","year":"2010","journal-title":"Mo. Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annepidem.2021.02.012","article-title":"COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis","volume":"57","author":"Macedo","year":"2021","journal-title":"Ann. Epidemiol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac381","article-title":"Applying lessons learned from COVID-19 therapeutic trials to improve future ALI\/ARDS trials","volume":"9","author":"Wu","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2025.115495_bb0085","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/CCM.0000000000004625","article-title":"Sepsis and coronavirus disease 2019: common features and anti-inflammatory therapeutic approaches","volume":"48","author":"Beltr\u00e1n-Garc\u00eda","year":"2020","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.46234\/ccdcw2020.017","article-title":"A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019-2020","volume":"2","author":"Tan","year":"2020","journal-title":"China CDC Wkly."},{"issue":"23","key":"10.1016\/j.intimp.2025.115495_bb0095","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.intimp.2025.115495_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/ars.2008.2231","article-title":"Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins","volume":"11","author":"Pendyala","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"47","key":"10.1016\/j.intimp.2025.115495_bb0110","doi-asserted-by":"crossref","first-page":"33644","DOI":"10.1074\/jbc.274.47.33644","volume":"274","author":"Ago","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115495_bb0115","first-page":"1","article-title":"Advanced development and mechanism of sepsis-related acute respiratory distress syndrome","volume":"9","author":"Gong","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.115495_bb0120","first-page":"1","article-title":"Regulation of endothelial barrier function, colloquium series on integrated systems physiology: from molecule to function","author":"Yuan","year":"2010","journal-title":"Morgan & Claypool Life Sciences"},{"issue":"14","key":"10.1016\/j.intimp.2025.115495_bb0125","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1128\/MCB.25.14.6259-6266.2005","article-title":"Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo","volume":"25","author":"Fazal","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2009-0197OC","article-title":"Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury","volume":"44","author":"Mirzapoiazova","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0135","first-page":"3376","article-title":"Effect of TLR4\/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response","volume":"15","author":"Zhou","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ccc.2021.05.009","article-title":"Pharmacologic treatments for acute respiratory distress syndrome","volume":"37","author":"Qadir","year":"2021","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.intimp.2025.115495_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2119\/molmed.2009.00097","article-title":"Pattern recognition receptor-dependent mechanisms of acute lung injury","volume":"16","author":"Xiang","year":"2010","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0150","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1183\/13993003.01282-2015","article-title":"Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions","volume":"47","author":"Short","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2025.115495_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12276","article-title":"Regulation of claudin\/zonula occludens-1 complexes by hetero-claudin interactions","volume":"7","author":"Schlingmann","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115495_bb0160","first-page":"1","article-title":"METTL3-mediated N6-Methyladenosine modification of Trim59 mRNA protects against Sepsis-induced acute respiratory distress syndrome","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115495_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.NPR.0000454981.96541.e6","article-title":"Effective management of ARDS","volume":"39","author":"Carlucci","year":"2014","journal-title":"Nurs. Pract."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2006-948288","article-title":"Pathophysiology of acute lung injury and the acute respiratory distress syndrome","volume":"27","author":"Ware","year":"2006","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0175","first-page":"C449","article-title":"Acute downregulation of miR-199a attenuates sepsis-induced acute lung injury by targeting SIRT1","volume":"314","author":"Liu","year":"2018","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.intimp.2025.115495_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2022.931061","article-title":"Mechanism of COVID-19 causing ARDS: exploring the possibility of preventing and treating SARS-CoV-2","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0185","article-title":"Immune modulation in sepsis, ARDS, and Covid-19\u2014the road traveled and the road ahead","volume":"1","author":"Leligdowicz","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2025.115495_bb0195","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00011-020-01378-2","article-title":"Macrophage polarization and its role in the pathogenesis of acute lung injury\/acute respiratory distress syndrome","volume":"69","author":"Chen","year":"2020","journal-title":"Inflamm. Res."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2025.115495_bb0205","doi-asserted-by":"crossref","first-page":"74s","DOI":"10.1378\/chest.116.suppl_1.74S-a","article-title":"Epidemiology of acute lung injury and ARDS","volume":"116","author":"Hudson","year":"1999","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.09-2933","article-title":"Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS","volume":"138","author":"Sheu","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2025.115495_bb0215","series-title":"Annual Update in Intensive Care and Emergency Medicine 2012","author":"Vincent","year":"2012"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20200830","article-title":"From sepsis to acute respiratory distress syndrome (ARDS): emerging preventive strategies based on molecular and genetic researches","volume":"40","author":"Hu","year":"2020","journal-title":"Biosci. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2025.115495_bb0225","first-page":"1","article-title":"Therapeutic approaches in modulating the inflammatory and immunological response in patients with Sepsis, Acute Respiratory Distress Syndrome, and Pancreatitis: An Expert Opinion Review","volume":"13","author":"Mehta","year":"2021","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0230","first-page":"709","article-title":"Diverse macrophage populations mediate acute lung inflammation and resolution","volume":"306","author":"Aggarwal","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0235","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2025.115495_bb0240","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1084\/jem.20110525","article-title":"Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo","volume":"208","author":"Broermann","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.chom.2013.12.003","article-title":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival","volume":"15","author":"Rodrigue-Gervais","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1165\/rcmb.2017-0393OC","article-title":"Microparticulate caspase 1 regulates Gasdermin D and pulmonary vascular endothelial cell injury","volume":"59","author":"Mitra","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115495_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.02.028","article-title":"PICK1 deficiency exacerbates sepsis-associated acute lung injury and impairs glutathione synthesis via reduction of xCT","volume":"118","author":"Qian","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccc.2010.12.005","article-title":"Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury","volume":"27","author":"Cross","year":"2011","journal-title":"Crit. Care Clin."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/ers.10.92","article-title":"Pathogenesis of indirect (secondary) acute lung injury","volume":"5","author":"Perl","year":"2011","journal-title":"Expert Rev. Respir. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-7-125","article-title":"Role of TNFalpha in pulmonary pathophysiology","volume":"7","author":"Mukhopadhyay","year":"2006","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0275","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.bbrc.2016.08.163","article-title":"Necrostatin-1 protects against oleic acid-induced acute respiratory distress syndrome in rats","volume":"478","author":"Pan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2025.115495_bb0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-physiol-020518-114320","article-title":"Cell death in the lung: the apoptosis-necroptosis Axis","volume":"81","author":"Sauler","year":"2019","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0285","first-page":"L1023","article-title":"Nur77 attenuates endothelin-1 expression via downregulation of NF-\u03baB and p38 MAPK in A549 cells and in an ARDS rat model","volume":"311","author":"Jiang","year":"2016","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.intimp.2025.115495_bb0290","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2014.09.027","article-title":"Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells","volume":"77","author":"Qin","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2025.115495_bb0295","author":"Jingyuan"},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"G\u00fcnzel","year":"2013","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0305","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115495_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-316-5_1","article-title":"Advances in epigenetic technology","volume":"791","author":"Tollefsbol","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"27","key":"10.1016\/j.intimp.2025.115495_bb0315","doi-asserted-by":"crossref","first-page":"20940","DOI":"10.1074\/jbc.M110.115063","article-title":"MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance","volume":"285","author":"El Gazzar","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0320","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.0211074","article-title":"MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-\u03b1 during TLR4-induced gene reprogramming","volume":"90","author":"El Gazzar","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0325","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/adb.12037","article-title":"Genome-wide DNA methylation analysis in alcohol dependence","volume":"18","author":"Zhang","year":"2013","journal-title":"Addict. Biol."},{"issue":"16","key":"10.1016\/j.intimp.2025.115495_bb0330","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region","volume":"323","author":"Grasselli","year":"2020","journal-title":"Italy, JAMA"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0335","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0340","first-page":"1","article-title":"Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning","volume":"11","author":"Xu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115495_bb0345","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.2147\/JIR.S334043","article-title":"Acute respiratory distress syndrome and COVID-19: a literature review","volume":"14","author":"Hussain","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0350","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.intimp.2025.115495_bb0355","doi-asserted-by":"crossref","first-page":"e2029050","DOI":"10.1001\/jamanetworkopen.2020.29050","article-title":"Assessment of machine learning to estimate the individual treatment effect of corticosteroids in septic shock","volume":"3","author":"Pirracchio","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.intimp.2025.115495_bb0360","first-page":"A2523","article-title":"Descriptive comparison between pre-COVID ARDS and COVID-19 related ARDS. TP48 TP048 COVID: ARDS CLINICAL STUDIES","author":"Hache-Marliere","year":"2021","journal-title":"Am. Thor. Soc."},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0365","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115495_bb0370","article-title":"Inflammation-induced coagulopathy substantially differs between COVID-19 and septic shock: a prospective observational study","volume":"8","author":"Dechamps","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.115495_bb0375","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2021.06.033","article-title":"Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation","volume":"336","author":"Mertes","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13054-021-03491-y","article-title":"Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method","volume":"25","author":"Nasa","year":"2021","journal-title":"Crit. Care"},{"issue":"13","key":"10.1016\/j.intimp.2025.115495_bb0385","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with Sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2025.115495_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155389","article-title":"Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients","volume":"138","author":"B\u00fclow Anderberg","year":"2021","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0395","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jmv.27592","article-title":"Angiotensin II infusion in COVID-19: an international, multicenter, registry-based study","volume":"94","author":"Serpa Neto","year":"2022","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0400","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13613-024-01386-z","article-title":"Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial","volume":"14","author":"Landoni","year":"2024","journal-title":"Ann. Intensive Care"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s43044-021-00208-y","article-title":"Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale","volume":"73","author":"Mulia","year":"2021","journal-title":"Egypt. Heart J."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0410","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/biom.13603","article-title":"Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial","volume":"79","author":"Tsiatis","year":"2023","journal-title":"Biometrics"},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0415","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results","volume":"384","author":"Pan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0420","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s13063-022-06722-x","volume":"23","author":"Franco-Moreno","year":"2022","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0425","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmi.2022.10.015","article-title":"Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial","volume":"29","author":"Karampitsakos","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.intimp.2025.115495_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111954","article-title":"In silico drug repurposing in COVID-19: a network-based analysis","volume":"142","author":"Sibilio","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.intimp.2025.115495_bb0435","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/annrheumdis-2020-219517","article-title":"Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts","volume":"80","author":"Wong","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0440","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1186\/s13063-022-06518-z","article-title":"The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial","volume":"23","author":"Sheehan","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2025.115495_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119901","article-title":"Mesenchymal stem cells in SARS-CoV-2 infection: a hype or hope","volume":"284","author":"Pal","year":"2021","journal-title":"Life Sci."},{"issue":"17","key":"10.1016\/j.intimp.2025.115495_bb0450","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13578-022-00899-z","article-title":"Revisiting potential value of antitumor drugs in the treatment of COVID-19","volume":"12","author":"Zheng","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2025.115495_bb0460","article-title":"Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19","author":"Uckun","year":"2022","journal-title":"medRxiv"},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0465","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.115495_bb0470","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/14787210.2021.1851197","article-title":"COVID-19 and inhibitors of the renin-angiotensin-aldosterone system","volume":"19","author":"Hussain","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0475","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2008-03-146720","article-title":"Differential requirement for the activation of the inflammasome for processing and release of IL-1\u03b2 in monocytes and macrophages","volume":"113","author":"Netea","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0480","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ccc.2021.05.009","article-title":"Pharmacologic treatments for acute respiratory distress syndrome","volume":"37","author":"Qadir","year":"2021","journal-title":"Crit. Care Clin."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0485","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/ph17040472","article-title":"Mechanisms of Sepsis-induced acute lung injury and advancements of natural small molecules in its treatment","volume":"17","author":"Xu","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0490","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12931-024-02678-5","article-title":"Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)","volume":"25","author":"Huang","year":"2024","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0500","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1002\/jcp.29586","article-title":"\u03b1(2A) -AR antagonism by BRL-44408 maleate attenuates acute lung injury in rats with downregulation of ERK1\/2, p38MAPK, and p65 pathway","volume":"235","author":"Cong","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0505","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.3390\/ijms23105545","article-title":"MicroRNAs: important regulatory molecules in acute lung injury\/acute respiratory distress syndrome","volume":"23","author":"Lu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0510","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7150\/ijbs.77304","article-title":"TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury","volume":"19","author":"Zhong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"7203","key":"10.1016\/j.intimp.2025.115495_bb0515","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115495_bb0520","doi-asserted-by":"crossref","first-page":"41363","DOI":"10.1038\/srep41363","article-title":"Cold-inducible RNA-binding protein (CIRP) causes sepsis-associated acute lung injury via induction of endoplasmic reticulum stress","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0525","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3390\/ijms19082460","article-title":"TGF-\u03b2 signaling in lung health and disease","volume":"19","author":"Saito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0530","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200228RRRRR","article-title":"Transforming growth factor-\u03b2 receptor type 2 is required for heparin-binding protein-induced acute lung injury and vascular leakage for transforming growth factor-\u03b2\/Smad\/rho signaling pathway activation","volume":"36","author":"Liu","year":"2022","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0535","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-018-1247-9","article-title":"Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-\u03b1 mediated NF-\u03baB and HDAC-3 nuclear translocation","volume":"10","author":"Pooladanda","year":"2019","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0540","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/rccm.200509-1527OC","article-title":"Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice","volume":"175","author":"Cho","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120782","article-title":"Deciphering the role of damage-associated molecular patterns and inflammatory responses in acute lung injury","volume":"305","author":"Hsieh","year":"2022","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0550","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00134-012-2624-y","article-title":"The receptor for advanced glycation end products and acute lung injury\/acute respiratory distress syndrome","volume":"38","author":"Guo","year":"2012","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0555","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ijms19020588","article-title":"New insights into the immune molecular regulation of the pathogenesis of acute respiratory distress syndrome","volume":"19","author":"Yang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"38","key":"10.1016\/j.intimp.2025.115495_bb0560","doi-asserted-by":"crossref","first-page":"33083","DOI":"10.1074\/jbc.M503173200","article-title":"Myosin phosphatase and cofilin mediate cAMP\/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation","volume":"280","author":"Goeckeler","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0565","doi-asserted-by":"crossref","first-page":"13156","DOI":"10.1096\/fj.202001607R","article-title":"The cGAS-STING pathway: the role of self-DNA sensing in inflammatory lung disease","volume":"34","author":"Ma","year":"2020","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0570","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41401-021-00813-2","article-title":"STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion","volume":"43","author":"Wu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"22","key":"10.1016\/j.intimp.2025.115495_bb0575","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.intimp.2025.115495_bb0580","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.3390\/ijms22168406","article-title":"An update on the role of Nrf2 in respiratory disease: molecular mechanisms and therapeutic approaches","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0585","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.21037\/jtd-24-1191","article-title":"Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: a narrative review","volume":"16","author":"Zhang","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0590","first-page":"24","article-title":"Acute respiratory distress syndrome mimics: the role of lung biopsy","volume":"23","author":"Aublanc","year":"2017","journal-title":"Curr. Opin. Crit. Care"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0595","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/ajrccm.158.1.9708031","article-title":"Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?","volume":"158","author":"Gattinoni","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0600","series-title":"Acute Respiratory Distress Syndrome, StatPearls, StatPearls Publishing Copyright \u00a9 2022","author":"Diamond","year":"2022"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0605","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/CCM.0b013e31819fefdf","article-title":"Recent trends in acute lung injury mortality: 1996-2005","volume":"37","author":"Erickson","year":"2009","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0610","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2025.115495_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1277161","article-title":"Acute respiratory distress syndrome heterogeeity and the septic ARDS subgroup","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0620","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1378\/chest.11-1766","article-title":"The association between a Darc gene polymorphism and clinical outcomes in African American patients with acute lung injury","volume":"141","author":"Kangelaris","year":"2012","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.intimp.2025.115495_bb0625","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/00003246-200007000-00001","article-title":"Diabetic patients have a decreased incidence of acute respiratory distress syndrome","volume":"28","author":"Moss","year":"2000","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0630","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.1996.03530250054027","article-title":"The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults","volume":"275","author":"Moss","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0635","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/2224-4018.141831","article-title":"Role of genetic factors in the development of acute respiratory distress syndrome","volume":"2","author":"Liu","year":"2015","journal-title":"J. Transl. Intern. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0640","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0033-1351121","article-title":"Genetic heterogeneity and risk of acute respiratory distress syndrome","volume":"34","author":"Meyer","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0645","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0650","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2017.17687","article-title":"Enhancing recovery from Sepsis: a review","volume":"319","author":"Prescott","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0655","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0660","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0665","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0670","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0042-1749450","article-title":"Mechanical ventilation during ECMO: lessons from clinical trials and future prospects","volume":"43","author":"Fior","year":"2022","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0675","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMsa1410639","article-title":"Driving pressure and survival in the acute respiratory distress syndrome","volume":"372","author":"Amato","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115495_bb0680","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jama.2010.218","article-title":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis","volume":"303","author":"Briel","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0685","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.299.6.637","article-title":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial","volume":"299","author":"Meade","year":"2008","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0690","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.201901-0109OC","article-title":"Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial","volume":"200","author":"Hodgson","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"14","key":"10.1016\/j.intimp.2025.115495_bb0695","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2017.14171","article-title":"Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial","volume":"318","author":"Cavalcanti","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0700","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2213-2600(18)30452-1","article-title":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"7","author":"Munshi","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"21","key":"10.1016\/j.intimp.2025.115495_bb0705","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"9698","key":"10.1016\/j.intimp.2025.115495_bb0710","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0715","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5811\/westjem.2020.10.47825","article-title":"Norepinephrine in septic shock: a systematic review and Meta-analysis","volume":"22","author":"Ruslan","year":"2021","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0720","doi-asserted-by":"crossref","unstructured":"A.C. Gordon, A.J. Mason, N. Thirunavukkarasu, G.D. Perkins, M. Cecconi, M. Cepkova, D.G. Pogson, H.D. Aya, A. Anjum, G.J. Frazier, S. Santhakumaran, D. Ashby, S.J. Brett, Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial, J 316(5) (2016) 509\u201318.","DOI":"10.1001\/jama.2016.10485"},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0725","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3390\/ijms24044103","article-title":"Norepinephrine and vasopressin in hemorrhagic shock: a focus on renal hemodynamics","volume":"24","author":"Fage","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0730","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/cc9411","article-title":"Clinical review: blood purification for sepsis","volume":"15","author":"Rimmel\u00e9","year":"2011","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.intimp.2025.115495_bb0735","article-title":"Corticosteroids for treating sepsis","volume":"2015","author":"Annane","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2025.115495_bb0740","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for Sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0745","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archsurg.1985.01390290018003","article-title":"Early steroid therapy for respiratory failure","volume":"120","author":"Weigelt","year":"1985","journal-title":"Arch. Surg."},{"issue":"25","key":"10.1016\/j.intimp.2025.115495_bb0750","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"High-dose corticosteroids in patients with the adult respiratory distress syndrome","volume":"317","author":"Bernard","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.115495_bb0755","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0760","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0765","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/PCC.0000000000000349","article-title":"Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome","volume":"16","author":"Drago","year":"2015","journal-title":"Pediatr. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0770","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2025.115495_bb0775","first-page":"1","article-title":"The controversy about the effects of different doses of corticosteroid treatment on clinical outcomes for acute respiratory distress syndrome patients: an observational study","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0780","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cpt.1034","article-title":"Acute respiratory distress syndrome: bench-to-bedside approaches to improve drug development","volume":"104","author":"Hussain","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0785","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/CCM.0000000000000789","article-title":"Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis","volume":"43","author":"Chen","year":"2015","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115495_bb0790","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200803-419OC","article-title":"Randomized clinical trial of activated protein C for the treatment of acute lung injury","volume":"178","author":"Liu","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-1091-6","article-title":"Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome","volume":"19","author":"Toner","year":"2015","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0800","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5935\/0103-507X.20170044","article-title":"What every intensivist should know about acute respiratory distress syndrome and diffuse alveolar damage","volume":"29","author":"Rios","year":"2017","journal-title":"Rev. Bras. Ter. Intensiva"},{"issue":"18","key":"10.1016\/j.intimp.2025.115495_bb0805","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.intimp.2025.115495_bb0810","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"Truwit","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115495_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2018-025523","article-title":"Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.intimp.2025.115495_bb0820","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074756","article-title":"Effects of intravenous sivelestat sodium on prevention of acute respiratory distress syndrome in patients with sepsis: study protocol for a double-blind multicentre randomised controlled trial","volume":"13","author":"Ma","year":"2023","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.intimp.2025.115495_bb0825","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1021\/acs.jmedchem.4c00823","article-title":"Carbon monoxide as a potential therapeutic agent: a molecular analysis of its safety profiles","volume":"67","author":"Bansal","year":"2024","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.intimp.2025.115495_bb0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.124039","article-title":"A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS","volume":"3","author":"Fredenburgh","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.115495_bb0835","unstructured":"Xinhua Hospital, Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury, 2021. (https:\/\/clinicaltrials.gov\/study\/NCT04940676?cond=NCT04940676&rank=1)."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0840","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CCM.0b013e31822d7bf0","article-title":"A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury","volume":"40","author":"Paine","year":"2012","journal-title":"Crit. Care Med."},{"issue":"26","key":"10.1016\/j.intimp.2025.115495_bb0845","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1911124","article-title":"Early high-dose vitamin D(3) for critically ill, vitamin D-deficient patients","volume":"381","author":"Ginde","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0850","doi-asserted-by":"crossref","DOI":"10.2196\/55880","article-title":"The COSMOS registry of CytoSorb Hemoadsorption therapy in critically ill patients: protocol for an international, prospective registry","volume":"13","author":"Taccone","year":"2024","journal-title":"JMIR Res. Protoc."},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0855","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1916431","article-title":"Liberal or conservative oxygen therapy for acute respiratory distress syndrome","volume":"382","author":"Barrot","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0860","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2466-12-5","article-title":"A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome","volume":"12","author":"Morris","year":"2012","journal-title":"BMC Pulm. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0865","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/healthcare10112150","article-title":"Deep learning chest CT for clinically precise prediction of Sepsis-induced acute respiratory distress syndrome: a protocol for an observational Ambispective cohort study","volume":"10","author":"Li","year":"2022","journal-title":"Healthcare"},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0870","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.56609","article-title":"Effect of maternal and newborn care service package on perinatal and newborn mortality: a cluster randomized clinical trial","volume":"7","author":"Ariff","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0875","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/ALN.0000000000000862","article-title":"Physiological effects of the open lung approach in patients with early, mild, diffuse acute respiratory distress syndrome: an electrical impedance tomography study","volume":"123","author":"Cinnella","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.intimp.2025.115495_bb0880","author":"Vasco-Morales"},{"issue":"7","key":"10.1016\/j.intimp.2025.115495_bb0885","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0890","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.2009005","article-title":"A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction","volume":"166","author":"Presneill","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115495_bb0895","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/antibiotics13111047","article-title":"Nanoparticle-based nitric oxide donors: exploring their antimicrobial and anti-biofilm capabilities","volume":"13","author":"Tortella Fuentes","year":"2024","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0900","doi-asserted-by":"crossref","first-page":"433","DOI":"10.32604\/biocell.2022.018510","article-title":"Short term protective effect of digitoxin in sepsis-induced acute lung injury","volume":"46","author":"Bora","year":"2022","journal-title":"BIOCELL"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cimb46010001","article-title":"Gallic acid protects from Sepsis-induced acute lung injury","volume":"46","author":"Karda\u015f","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0910","first-page":"8","article-title":"Short-term protective effect of octreotide on the lungs of rats with experimentally induced sepsis","volume":"28","author":"Bora","year":"2022","journal-title":"Ulus. Travma Acil Cerrahi Derg."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0915","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1164\/rccm.201004-0549OC","article-title":"Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study","volume":"183","author":"Gajic","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115495_bb0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.08.037","article-title":"MicroRNA-494 inhibition alleviates acute lung injury through Nrf2 signaling pathway via NQO1 in sepsis-associated acute respiratory distress syndrome","volume":"210","author":"Ling","year":"2018","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.115495_bb0925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-016-2745-7","article-title":"Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression","volume":"419","author":"Zhou","year":"2016","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2025.115495_bb0930","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1165\/rcmb.2005-0404OC","article-title":"Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury","volume":"34","author":"Gao","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0935","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2007.03.019","article-title":"Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma","volume":"119","author":"Gao","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018764171","article-title":"Myosin light chain kinase (MYLK) coding polymorphisms modulate human lung endothelial cell barrier responses via altered tyrosine phosphorylation, spatial localization, and lamellipodial protrusions","volume":"8","author":"Wang","year":"2018","journal-title":"Pulm. Circ."},{"issue":"10","key":"10.1016\/j.intimp.2025.115495_bb0945","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1073\/pnas.1031595100","article-title":"Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment","volume":"100","author":"Wainwright","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.intimp.2025.115495_bb0950","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/SHK.0b013e31804d415f","article-title":"A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns","volume":"28","author":"Reynoso","year":"2007","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.intimp.2025.115495_bb0955","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.110.988915","article-title":"Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration","volume":"124","author":"Sun","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0960","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2353\/ajpath.2007.060219","article-title":"Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice","volume":"170","author":"Ralay Ranaivo","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115495_bb0965","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cvr\/cvq144","article-title":"Myosin light chain kinase in microvascular endothelial barrier function","volume":"87","author":"Shen","year":"2010","journal-title":"Cardiovasc. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:49:23Z","timestamp":1763696963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925014869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":192,"alternative-id":["S1567576925014869"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115495","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sepsis-induced ALI\/ARDS beyond supportive care: molecular mechanisms and cutting-edge therapies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115495"}}